Fix 340B Accountability to Ensure it Helps People it’s Intended for

Photo credit: 340B Report At BlackDoctor.org, we are committed to promoting equitable healthcare access for underserved communities. Dr. Farhan Bhatti’s compelling op-ed in The Detroit News on November 12th, highlights the urgent need to address unaffordable prescription drug prices. We strongly support his call for reform, while also emphasizing the need for transparency in the 340B Drug Pricing Program and across the pharmaceutical supply chain. Prescription drug costs continue to skyrocket, disproportionately impacting vulnerable populations, including communities of color. For individuals managing chronic conditions like diabetes or hypertension, the high cost of medication is a barrier to maintaining health and quality of life. Addressing these systemic inequities requires not only reigning in excessive pricing practices but also ensuring existing programs work as intended. The 340B Drug Pricing Program, created to assist hospitals and clinics serving low-income patients by providing discounted medications, has helped many in need. However, its lack of transparency has raised concerns that some participating entities may not reinvest these savings into patient care. Reforming the program to ensure its benefits are directly passed on to underserved patients is essential to uphold its original mission. During the lame duck session, Michigan legislators are quickly pushing SB 1179, which,...